1h Free Analyst Time
The global alzheimers disease therapeutics market is forecasted to grow by USD 6.44 billion during 2025-2030, accelerating at a CAGR of 10.0% during the forecast period. The report on the global alzheimers disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rapid expansion of aging demographics globally, technological advancements and commercialization of disease-modifying therapies, evolution of blood-based biomarker diagnostics and early intervention screening.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global alzheimers disease therapeutics market is segmented as below:
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- E-commerce pharmacy
By Drug Class
- Cholinesterase inhibitors
- N-methyl-D-aspartate receptor antagonist
- Others
By Therapeutic Area
- Symptomatic treatments
- Disease-modifying therapies
- Immunotherapies
- Gene therapies
- Small molecule inhibitors
By Region
- North America
- US
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- The Netherlands
- Spain
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
The report on the global alzheimers disease therapeutics market covers the following areas:
- Global alzheimers disease therapeutics market sizing
- Global alzheimers disease therapeutics market forecast
- Global alzheimers disease therapeutics market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by Therapeutic Area
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Alzheimers Disease Therapeutics Market 2020 - 2024
- Historic Market Size - Data Table on Global Alzheimers Disease Therapeutics Market 2020 - 2024 ($ million)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
- Historic Market Size - Therapeutic Area Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on global Alzheimers disease therapeutics market
6.2 Impact of geopolitical conflicts on global Alzheimers disease therapeutics market
6.2 Impact of geopolitical conflicts on global Alzheimers disease therapeutics market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Distribution Channel
8.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
- Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
- Chart on E-commerce pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on E-commerce pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on E-commerce pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on E-commerce pharmacy - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Drug Class
9.1 Market segments
- Chart on Drug Class - Market share 2025-2030 (%)
- Data Table on Drug Class - Market share 2025-2030 (%)
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- Chart on Cholinesterase inhibitors - Market size and forecast 2025-2030 ($ million)
- Data Table on Cholinesterase inhibitors - Market size and forecast 2025-2030 ($ million)
- Chart on Cholinesterase inhibitors - Year-over-year growth 2025-2030 (%)
- Data Table on Cholinesterase inhibitors - Year-over-year growth 2025-2030 (%)
- Chart on N-methyl-D-aspartate receptor antagonist - Market size and forecast 2025-2030 ($ million)
- Data Table on N-methyl-D-aspartate receptor antagonist - Market size and forecast 2025-2030 ($ million)
- Chart on N-methyl-D-aspartate receptor antagonist - Year-over-year growth 2025-2030 (%)
- Data Table on N-methyl-D-aspartate receptor antagonist - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
10 Market Segmentation by Therapeutic Area
10.1 Market segments
- Chart on Therapeutic Area - Market share 2025-2030 (%)
- Data Table on Therapeutic Area - Market share 2025-2030 (%)
- Chart on Comparison by Therapeutic Area
- Data Table on Comparison by Therapeutic Area
- Chart on Symptomatic treatments - Market size and forecast 2025-2030 ($ million)
- Data Table on Symptomatic treatments - Market size and forecast 2025-2030 ($ million)
- Chart on Symptomatic treatments - Year-over-year growth 2025-2030 (%)
- Data Table on Symptomatic treatments - Year-over-year growth 2025-2030 (%)
- Chart on Disease-modifying therapies - Market size and forecast 2025-2030 ($ million)
- Data Table on Disease-modifying therapies - Market size and forecast 2025-2030 ($ million)
- Chart on Disease-modifying therapies - Year-over-year growth 2025-2030 (%)
- Data Table on Disease-modifying therapies - Year-over-year growth 2025-2030 (%)
- Chart on Immunotherapies - Market size and forecast 2025-2030 ($ million)
- Data Table on Immunotherapies - Market size and forecast 2025-2030 ($ million)
- Chart on Immunotherapies - Year-over-year growth 2025-2030 (%)
- Data Table on Immunotherapies - Year-over-year growth 2025-2030 (%)
- Chart on Gene therapies - Market size and forecast 2025-2030 ($ million)
- Data Table on Gene therapies - Market size and forecast 2025-2030 ($ million)
- Chart on Gene therapies - Year-over-year growth 2025-2030 (%)
- Data Table on Gene therapies - Year-over-year growth 2025-2030 (%)
- Chart on Small molecule inhibitors - Market size and forecast 2025-2030 ($ million)
- Data Table on Small molecule inhibitors - Market size and forecast 2025-2030 ($ million)
- Chart on Small molecule inhibitors - Year-over-year growth 2025-2030 (%)
- Data Table on Small molecule inhibitors - Year-over-year growth 2025-2030 (%)
- Market opportunity by Therapeutic Area ($ million)
- Data Table on Market opportunity by Therapeutic Area ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Australia - Market size and forecast 2025-2030 ($ million)
- Data Table on Australia - Market size and forecast 2025-2030 ($ million)
- Chart on Australia - Year-over-year growth 2025-2030 (%)
- Data Table on Australia - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ million)
- Data Table on Israel - Market size and forecast 2025-2030 ($ million)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Rapid expansion of aging demographics globally
- Technological advancements and commercialization of disease-modifying therapies
- Evolution of blood-based biomarker diagnostics and early intervention screening
- High clinical trial attrition rates and atrophy of developmental pipelines
- Drastic payer restraints and stringent coverage with evidence development mandates
- Diagnostic infrastructure deficiencies and quality control volatility in biomarker testing
- Impact of drivers and challenges in 2025 and 2030
- Decentralization of treatment delivery and rise of at-home subcutaneous biologics
- Strategic convergence of multi-target combinations and non-amyloid modalities
- Proliferation of digital biomarkers and remote cognitive monitoring infrastructure
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key offerings
- SWOT
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
- Eisai Co. Ltd. - Overview
- Eisai Co. Ltd. - Business segments
- Eisai Co. Ltd. - Key offerings
- Eisai Co. Ltd. - Segment focus
- SWOT
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
- H. Lundbeck AS - Overview
- H. Lundbeck AS - Product / Service
- H. Lundbeck AS - Key offerings
- SWOT
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- Luye Pharma Group Ltd. - Overview
- Luye Pharma Group Ltd. - Business segments
- Luye Pharma Group Ltd. - Key offerings
- Luye Pharma Group Ltd. - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Sun Pharmaceutical Industries - Overview
- Sun Pharmaceutical Industries - Business segments
- Sun Pharmaceutical Industries - Key news
- Sun Pharmaceutical Industries - Key offerings
- Sun Pharmaceutical Industries - Segment focus
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
- Torrent Pharmaceuticals Ltd. - Overview
- Torrent Pharmaceuticals Ltd. - Product / Service
- Torrent Pharmaceuticals Ltd. - Key offerings
- SWOT
- Unichem Laboratories Ltd - Overview
- Unichem Laboratories Ltd - Product / Service
- Unichem Laboratories Ltd - Key offerings
- SWOT
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 7: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Alzheimers Disease Therapeutics Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Therapeutic Area Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 39: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Distribution Channel
Exhibit 41: Data Table on Comparison by Distribution Channel
Exhibit 42: Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on E-commerce pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on E-commerce pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on E-commerce pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on E-commerce pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Distribution Channel ($ million)
Exhibit 55: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 56: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 57: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Drug Class
Exhibit 59: Data Table on Comparison by Drug Class
Exhibit 60: Chart on Cholinesterase inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Cholinesterase inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Cholinesterase inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Cholinesterase inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on N-methyl-D-aspartate receptor antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on N-methyl-D-aspartate receptor antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on N-methyl-D-aspartate receptor antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on N-methyl-D-aspartate receptor antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 72: Market opportunity by Drug Class ($ million)
Exhibit 73: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 74: Chart on Therapeutic Area - Market share 2025-2030 (%)
Exhibit 75: Data Table on Therapeutic Area - Market share 2025-2030 (%)
Exhibit 76: Chart on Comparison by Therapeutic Area
Exhibit 77: Data Table on Comparison by Therapeutic Area
Exhibit 78: Chart on Symptomatic treatments - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Symptomatic treatments - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Symptomatic treatments - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Symptomatic treatments - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Disease-modifying therapies - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Disease-modifying therapies - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Disease-modifying therapies - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Disease-modifying therapies - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Immunotherapies - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Immunotherapies - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Immunotherapies - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Immunotherapies - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Gene therapies - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Gene therapies - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Gene therapies - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Gene therapies - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Small molecule inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Small molecule inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Small molecule inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Small molecule inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 98: Market opportunity by Therapeutic Area ($ million)
Exhibit 99: Data Table on Market opportunity by Therapeutic Area ($ million)
Exhibit 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 101: Chart on Market share by geography 2025-2030 (%)
Exhibit 102: Data Table on Market share by geography 2025-2030 (%)
Exhibit 103: Chart on Geographic comparison
Exhibit 104: Data Table on Geographic comparison
Exhibit 105: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 107: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 108: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 109: Chart on Regional Comparison - North America
Exhibit 110: Data Table on Regional Comparison - North America
Exhibit 111: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Regional Comparison - Europe
Exhibit 128: Data Table on Regional Comparison - Europe
Exhibit 129: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Regional Comparison - Asia
Exhibit 158: Data Table on Regional Comparison - Asia
Exhibit 159: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 188: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 189: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 221: Market opportunity by geography ($ million)
Exhibit 222: Data Tables on Market opportunity by geography ($ million)
Exhibit 223: Impact of drivers and challenges in 2025 and 2030
Exhibit 224: Overview on criticality of inputs and factors of differentiation
Exhibit 225: Overview on factors of disruption
Exhibit 226: Impact of key risks on business
Exhibit 227: Companies covered
Exhibit 228: Company ranking index
Exhibit 229: Matrix on companies position and classification
Exhibit 230: Biogen Inc. - Overview
Exhibit 231: Biogen Inc. - Product / Service
Exhibit 232: Biogen Inc. - Key offerings
Exhibit 233: SWOT
Exhibit 234: Cipla Inc. - Overview
Exhibit 235: Cipla Inc. - Business segments
Exhibit 236: Cipla Inc. - Key news
Exhibit 237: Cipla Inc. - Key offerings
Exhibit 238: Cipla Inc. - Segment focus
Exhibit 239: SWOT
Exhibit 240: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 241: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 242: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 243: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 244: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 245: SWOT
Exhibit 246: Eisai Co. Ltd. - Overview
Exhibit 247: Eisai Co. Ltd. - Business segments
Exhibit 248: Eisai Co. Ltd. - Key offerings
Exhibit 249: Eisai Co. Ltd. - Segment focus
Exhibit 250: SWOT
Exhibit 251: Eli Lilly and Co. - Overview
Exhibit 252: Eli Lilly and Co. - Product / Service
Exhibit 253: Eli Lilly and Co. - Key offerings
Exhibit 254: SWOT
Exhibit 255: H. Lundbeck AS - Overview
Exhibit 256: H. Lundbeck AS - Product / Service
Exhibit 257: H. Lundbeck AS - Key offerings
Exhibit 258: SWOT
Exhibit 259: Lupin Ltd. - Overview
Exhibit 260: Lupin Ltd. - Business segments
Exhibit 261: Lupin Ltd. - Key news
Exhibit 262: Lupin Ltd. - Key offerings
Exhibit 263: Lupin Ltd. - Segment focus
Exhibit 264: SWOT
Exhibit 265: Luye Pharma Group Ltd. - Overview
Exhibit 266: Luye Pharma Group Ltd. - Business segments
Exhibit 267: Luye Pharma Group Ltd. - Key offerings
Exhibit 268: Luye Pharma Group Ltd. - Segment focus
Exhibit 269: SWOT
Exhibit 270: Novartis AG - Overview
Exhibit 271: Novartis AG - Business segments
Exhibit 272: Novartis AG - Key news
Exhibit 273: Novartis AG - Key offerings
Exhibit 274: Novartis AG - Segment focus
Exhibit 275: SWOT
Exhibit 276: Sun Pharmaceutical Industries - Overview
Exhibit 277: Sun Pharmaceutical Industries - Business segments
Exhibit 278: Sun Pharmaceutical Industries - Key news
Exhibit 279: Sun Pharmaceutical Industries - Key offerings
Exhibit 280: Sun Pharmaceutical Industries - Segment focus
Exhibit 281: SWOT
Exhibit 282: Teva Pharmaceutical Ltd. - Overview
Exhibit 283: Teva Pharmaceutical Ltd. - Business segments
Exhibit 284: Teva Pharmaceutical Ltd. - Key news
Exhibit 285: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 286: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 287: SWOT
Exhibit 288: Torrent Pharmaceuticals Ltd. - Overview
Exhibit 289: Torrent Pharmaceuticals Ltd. - Product / Service
Exhibit 290: Torrent Pharmaceuticals Ltd. - Key offerings
Exhibit 291: SWOT
Exhibit 292: Unichem Laboratories Ltd - Overview
Exhibit 293: Unichem Laboratories Ltd - Product / Service
Exhibit 294: Unichem Laboratories Ltd - Key offerings
Exhibit 295: SWOT
Exhibit 296: Viatris Inc. - Overview
Exhibit 297: Viatris Inc. - Business segments
Exhibit 298: Viatris Inc. - Key news
Exhibit 299: Viatris Inc. - Key offerings
Exhibit 300: Viatris Inc. - Segment focus
Exhibit 301: SWOT
Exhibit 302: Zydus Lifesciences Ltd. - Overview
Exhibit 303: Zydus Lifesciences Ltd. - Business segments
Exhibit 304: Zydus Lifesciences Ltd. - Key news
Exhibit 305: Zydus Lifesciences Ltd. - Key offerings
Exhibit 306: Zydus Lifesciences Ltd. - Segment focus
Exhibit 307: SWOT
Exhibit 308: Inclusions checklist
Exhibit 309: Exclusions checklist
Exhibit 310: Currency conversion rates for US$
Exhibit 311: Research methodology
Exhibit 312: Information sources
Exhibit 313: Data validation
Exhibit 314: Validation techniques employed for market sizing
Exhibit 315: Data synthesis
Exhibit 316: 360 degree market analysis
Exhibit 317: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 7: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Alzheimers Disease Therapeutics Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Therapeutic Area Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 39: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Distribution Channel
Exhibit 41: Data Table on Comparison by Distribution Channel
Exhibit 42: Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on E-commerce pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on E-commerce pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on E-commerce pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on E-commerce pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Distribution Channel ($ million)
Exhibit 55: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 56: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 57: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Drug Class
Exhibit 59: Data Table on Comparison by Drug Class
Exhibit 60: Chart on Cholinesterase inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Cholinesterase inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Cholinesterase inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Cholinesterase inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on N-methyl-D-aspartate receptor antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on N-methyl-D-aspartate receptor antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on N-methyl-D-aspartate receptor antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on N-methyl-D-aspartate receptor antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 72: Market opportunity by Drug Class ($ million)
Exhibit 73: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 74: Chart on Therapeutic Area - Market share 2025-2030 (%)
Exhibit 75: Data Table on Therapeutic Area - Market share 2025-2030 (%)
Exhibit 76: Chart on Comparison by Therapeutic Area
Exhibit 77: Data Table on Comparison by Therapeutic Area
Exhibit 78: Chart on Symptomatic treatments - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Symptomatic treatments - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Symptomatic treatments - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Symptomatic treatments - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Disease-modifying therapies - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Disease-modifying therapies - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Disease-modifying therapies - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Disease-modifying therapies - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Immunotherapies - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Immunotherapies - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Immunotherapies - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Immunotherapies - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Gene therapies - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Gene therapies - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Gene therapies - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Gene therapies - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Small molecule inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Small molecule inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Small molecule inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Small molecule inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 98: Market opportunity by Therapeutic Area ($ million)
Exhibit 99: Data Table on Market opportunity by Therapeutic Area ($ million)
Exhibit 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 101: Chart on Market share by geography 2025-2030 (%)
Exhibit 102: Data Table on Market share by geography 2025-2030 (%)
Exhibit 103: Chart on Geographic comparison
Exhibit 104: Data Table on Geographic comparison
Exhibit 105: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 107: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 108: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 109: Chart on Regional Comparison - North America
Exhibit 110: Data Table on Regional Comparison - North America
Exhibit 111: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Regional Comparison - Europe
Exhibit 128: Data Table on Regional Comparison - Europe
Exhibit 129: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Regional Comparison - Asia
Exhibit 158: Data Table on Regional Comparison - Asia
Exhibit 159: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 188: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 189: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 221: Market opportunity by geography ($ million)
Exhibit 222: Data Tables on Market opportunity by geography ($ million)
Exhibit 223: Impact of drivers and challenges in 2025 and 2030
Exhibit 224: Overview on criticality of inputs and factors of differentiation
Exhibit 225: Overview on factors of disruption
Exhibit 226: Impact of key risks on business
Exhibit 227: Companies covered
Exhibit 228: Company ranking index
Exhibit 229: Matrix on companies position and classification
Exhibit 230: Biogen Inc. - Overview
Exhibit 231: Biogen Inc. - Product / Service
Exhibit 232: Biogen Inc. - Key offerings
Exhibit 233: SWOT
Exhibit 234: Cipla Inc. - Overview
Exhibit 235: Cipla Inc. - Business segments
Exhibit 236: Cipla Inc. - Key news
Exhibit 237: Cipla Inc. - Key offerings
Exhibit 238: Cipla Inc. - Segment focus
Exhibit 239: SWOT
Exhibit 240: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 241: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 242: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 243: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 244: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 245: SWOT
Exhibit 246: Eisai Co. Ltd. - Overview
Exhibit 247: Eisai Co. Ltd. - Business segments
Exhibit 248: Eisai Co. Ltd. - Key offerings
Exhibit 249: Eisai Co. Ltd. - Segment focus
Exhibit 250: SWOT
Exhibit 251: Eli Lilly and Co. - Overview
Exhibit 252: Eli Lilly and Co. - Product / Service
Exhibit 253: Eli Lilly and Co. - Key offerings
Exhibit 254: SWOT
Exhibit 255: H. Lundbeck AS - Overview
Exhibit 256: H. Lundbeck AS - Product / Service
Exhibit 257: H. Lundbeck AS - Key offerings
Exhibit 258: SWOT
Exhibit 259: Lupin Ltd. - Overview
Exhibit 260: Lupin Ltd. - Business segments
Exhibit 261: Lupin Ltd. - Key news
Exhibit 262: Lupin Ltd. - Key offerings
Exhibit 263: Lupin Ltd. - Segment focus
Exhibit 264: SWOT
Exhibit 265: Luye Pharma Group Ltd. - Overview
Exhibit 266: Luye Pharma Group Ltd. - Business segments
Exhibit 267: Luye Pharma Group Ltd. - Key offerings
Exhibit 268: Luye Pharma Group Ltd. - Segment focus
Exhibit 269: SWOT
Exhibit 270: Novartis AG - Overview
Exhibit 271: Novartis AG - Business segments
Exhibit 272: Novartis AG - Key news
Exhibit 273: Novartis AG - Key offerings
Exhibit 274: Novartis AG - Segment focus
Exhibit 275: SWOT
Exhibit 276: Sun Pharmaceutical Industries - Overview
Exhibit 277: Sun Pharmaceutical Industries - Business segments
Exhibit 278: Sun Pharmaceutical Industries - Key news
Exhibit 279: Sun Pharmaceutical Industries - Key offerings
Exhibit 280: Sun Pharmaceutical Industries - Segment focus
Exhibit 281: SWOT
Exhibit 282: Teva Pharmaceutical Ltd. - Overview
Exhibit 283: Teva Pharmaceutical Ltd. - Business segments
Exhibit 284: Teva Pharmaceutical Ltd. - Key news
Exhibit 285: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 286: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 287: SWOT
Exhibit 288: Torrent Pharmaceuticals Ltd. - Overview
Exhibit 289: Torrent Pharmaceuticals Ltd. - Product / Service
Exhibit 290: Torrent Pharmaceuticals Ltd. - Key offerings
Exhibit 291: SWOT
Exhibit 292: Unichem Laboratories Ltd - Overview
Exhibit 293: Unichem Laboratories Ltd - Product / Service
Exhibit 294: Unichem Laboratories Ltd - Key offerings
Exhibit 295: SWOT
Exhibit 296: Viatris Inc. - Overview
Exhibit 297: Viatris Inc. - Business segments
Exhibit 298: Viatris Inc. - Key news
Exhibit 299: Viatris Inc. - Key offerings
Exhibit 300: Viatris Inc. - Segment focus
Exhibit 301: SWOT
Exhibit 302: Zydus Lifesciences Ltd. - Overview
Exhibit 303: Zydus Lifesciences Ltd. - Business segments
Exhibit 304: Zydus Lifesciences Ltd. - Key news
Exhibit 305: Zydus Lifesciences Ltd. - Key offerings
Exhibit 306: Zydus Lifesciences Ltd. - Segment focus
Exhibit 307: SWOT
Exhibit 308: Inclusions checklist
Exhibit 309: Exclusions checklist
Exhibit 310: Currency conversion rates for US$
Exhibit 311: Research methodology
Exhibit 312: Information sources
Exhibit 313: Data validation
Exhibit 314: Validation techniques employed for market sizing
Exhibit 315: Data synthesis
Exhibit 316: 360 degree market analysis
Exhibit 317: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global alzheimers disease therapeutics market: Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Biogen Inc., Cipla Inc., Dr. Reddys Laboratories Ltd., Eisai Co. Ltd., Eli Lilly and Co., H. Lundbeck AS, Lannett Co Inc., Lupin Ltd., Luye Pharma Group Ltd., Novartis AG, Otsuka Pharmaceutical Co Ltd., Sun Pharmaceutical Industries, Teva Pharmaceutical Ltd., Torrent Pharmaceuticals Ltd., Unichem Laboratories Ltd, Viatris Inc., Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is decentralization of treatment delivery and rise of at-home subcutaneous biologics."
According to the report, one of the major drivers for this market is the rapid expansion of aging demographics globally.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amneal Pharmaceuticals Inc.
- Apotex Inc.
- Aurobindo Pharma Ltd.
- Biogen Inc.
- Cipla Inc.
- Dr. Reddys Laboratories Ltd.
- Eisai Co. Ltd.
- Eli Lilly and Co.
- H. Lundbeck AS
- Lannett Co Inc.
- Lupin Ltd.
- Luye Pharma Group Ltd.
- Novartis AG
- Otsuka Pharmaceutical Co Ltd.
- Sun Pharmaceutical Industries
- Teva Pharmaceutical Ltd.
- Torrent Pharmaceuticals Ltd.
- Unichem Laboratories Ltd
- Viatris Inc.
- Zydus Lifesciences Ltd.
